Anavex Free Cash Flow vs Income Tax Expense Analysis
AVXL Stock | USD 3.41 0.27 7.34% |
Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Free Cash Flow and its Income Tax Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Free Cash Flow vs Income Tax Expense
Free Cash Flow vs Income Tax Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Free Cash Flow account and Income Tax Expense. At this time, the significance of the direction appears to have very week relationship.
The correlation between Anavex Life's Free Cash Flow and Income Tax Expense is 0.28. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Free Cash Flow and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Anavex Life Sciences are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Free Cash Flow i.e., Anavex Life's Free Cash Flow and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | 0.28 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Income Tax Expense
Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (7.39).
2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life fundamental ratios Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Other Current Liab | 3.3M | 5.6M | 5.9M | 7.3M | 8.4M | 8.8M | |
Total Current Liabilities | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
Total Stockholder Equity | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
Net Debt | (29.2M) | (152.1M) | (149.2M) | (151.0M) | (135.9M) | (129.1M) | |
Retained Earnings | (159.7M) | (197.6M) | (245.6M) | (293.1M) | (263.8M) | (250.6M) | |
Cash | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
Cash And Short Term Investments | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
Common Stock Total Equity | 52.7K | 62.0K | 75.9K | 77.9K | 89.6K | 94.1K | |
Common Stock Shares Outstanding | 58.2M | 69.8M | 76.9M | 79.8M | 91.8M | 96.3M | |
Liabilities And Stockholders Equity | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Other Stockholder Equity | 186.9M | 348.3M | 388.0M | 434.8M | 500.1M | 525.1M | |
Total Liab | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
Total Current Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Common Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 99.0K | |
Accounts Payable | 4.0M | 4.7M | 3.8M | 4.3M | 5.0M | 5.2M | |
Other Current Assets | 443.8K | 355.5K | 354.2K | 653K | 751.0K | 495.2K | |
Non Current Liabilities Total | 3.3M | 5.6M | 4.3M | 7.3M | 8.4M | 8.8M | |
Net Receivables | 4.8M | 9.1M | 3.2M | 2.7M | 3.1M | 2.1M | |
Net Tangible Assets | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
Retained Earnings Total Equity | (133.4M) | (159.7M) | (197.6M) | (245.6M) | (221.0M) | (210.0M) | |
Capital Surpluse | 153.6M | 186.9M | 348.3M | 388.0M | 446.2M | 468.5M | |
Net Invested Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
Net Working Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
Capital Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 72.7K |
Pair Trading with Anavex Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anavex Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anavex Life will appreciate offsetting losses from the drop in the long position's value.Moving against Anavex Stock
0.75 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
0.75 | NRSNW | NeuroSense Therapeutics | PairCorr |
0.71 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
0.7 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
0.68 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Anavex Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anavex Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anavex Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anavex Life Sciences to buy it.
The correlation of Anavex Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anavex Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anavex Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anavex Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Anavex Stock analysis
When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Return On Assets (0.21) | Return On Equity (0.32) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.